P
Prosemble develops advanced cancer treatments by integrating proprietary protein-based nanoparticle delivery systems with artificial intelligence. This technology enables disease-specific targeting and precise drug loading to enhance therapeutic efficacy in oncology. The platform aims to improve treatment outcomes while significantly reducing the systemic side effects associated with conventional chemotherapy.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Prosemble develops advanced cancer treatments by integrating proprietary protein-based nanoparticle delivery systems with artificial intelligence. This technology enables disease-specific targeting and precise drug loading to enhance therapeutic efficacy in oncology. The platform aims to improve treatment outcomes while significantly reducing the systemic side effects associated with conventional chemotherapy.